WJA
TDOC icon

Willis Johnson & Associates’s Teladoc Health TDOC Stock Holding History

Willis Johnson & Associates’s Portfolio TDOC Stock Details TDOC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1,587
Closed -$201K – 105
2021
Q3 		$201K Buy
1,587
+5
+0.3% +$728 0.03% 92
2021
Q2 		$263K Buy
1,582
+237
+18% +$38.4K 0.04% 76
2021
Q1 		$244K Buy
+1,345
New +$312K 0.04% 77

Other funds holding TDOC

AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
KA
Kinnevik AB Stockholm, Sweden $65.6M AUM 25.95% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Willis Johnson & Associates's TDOC Position: Q4 2021 in Review

Willis Johnson & Associates sold out of Teladoc Health (TDOC) in Q4 2021, closing a stake of 1,587 shares — an estimated $201K sold.

Willis Johnson & Associates first reported a position in TDOC in Q1 2021 and held it in 3 quarters. The position peaked at $263K in Q2 2021. 729 funds tracked by Wall St. Rank hold TDOC as of Q4 2021.

  • Willis Johnson & Associates reported no remaining Teladoc Health position as of Q4 2021 after selling out during the quarter.
  • Willis Johnson & Associates sold 1,587 Teladoc Health shares in Q4 2021, an estimated $201K.
  • Willis Johnson & Associates first reported a position in Teladoc Health in Q1 2021 and held it in 3 quarters.
  • Willis Johnson & Associates's Teladoc Health position peaked at $263K in Q2 2021.
  • 729 funds tracked by Wall St. Rank held Teladoc Health as of Q4 2021.

Based on Willis Johnson & Associates's 13F filing for Q4 2021, filed 21 Jan 2022.